News Search

"My role is to ... be more than just the connector in the community, but also the link between the clinical world and the community," says HICCC Community Advisory Board Member Dr. Ginny Mantello.

A new study led by Dr. Andrew Lassman addresses safety and efficacy of infigratinib, a fibroblast growth factor receptor (FGFR)-tyrosine kinase inhibitor, for patients with recurrent glioblastomas.

The U.S. Preventative Services Task Force now recommends that colon cancer screening start at age 45, with increasing numbers of young people with colon cancer becoming a troubling trend.

Timothy Wang, MD, and Kelley Yan, MD, PhD, have each been awarded 2022 Annual Recognition Prizes from the American Gastroenterological Association (AGA).